Showing results (221-230 of 501) with videos related to

Sort By:
Pageof 51
Proceedings of the National Academy of Sciences of the United States of America|June 15, 2017
Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicingTeng Fei, Yiwen Chen, Tengfei Xiao, et al.
European Urology|July 19, 2017
A Systematic Review and Framework for the Use of Hormone Therapy with Salvage Radiation Therapy for Recurrent Prostate CancerDaniel E Spratt, Robert T Dess, Zachary S Zumsteg, et al.
JCO Precision Oncology|August 25, 2020
Circulating Tumor Cells as a Predictor of Treatment Response in Clinically Localized Prostate CancerSimpa S Salami, Udit Singhal, Daniel E Spratt, et al.
JAMA Oncology|June 3, 2021
Association of Molecular Subtypes With Differential Outcome to Apalutamide Treatment in Nonmetastatic Castration-Resistant Prostate CancerFelix Y Feng, Shibu Thomas, Fred Saad, et al.
Urology|December 29, 2020
Prostate Cancer Foundation Hormone-Sensitive Prostate Cancer Biomarker Working Group Meeting SummaryMartin R Hofmann, Maha Hussain, Scott M Dehm, et al.
Science Translational Medicine|June 15, 2022
Chronologically modified androgen receptor in recurrent castration-resistant prostate cancer and its therapeutic targetingMithila Sawant, Kiran Mahajan, Arun Renganathan, et al.
International Journal of Radiation Oncology, Biology, Physics|May 20, 2011
Chemo-IMRT of oropharyngeal cancer aiming to reduce dysphagia: swallowing organs late complication probabilities and dosimetric correlatesAvraham Eisbruch, Hyungjin M Kim, Felix Y Feng, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 23, 2020
A Phase Ib/IIa Study of the Pan-BET Inhibitor ZEN-3694 in Combination with Enzalutamide in Patients with Metastatic Castration-resistant Prostate CancerRahul R Aggarwal, Michael T Schweizer, David M Nanus, et al.
The Journal of Urology|January 22, 2025
An Artificial Intelligence-Digital Pathology Algorithm Predicts Survival After Radical Prostatectomy From the Prostate, Lung, Colorectal, and Ovarian Cancer TrialEric V Li, Yi Ren, Jacqueline Griffin, et al.
Genome Biology|October 7, 2024
In vivo perturb-seq of cancer and microenvironment cells dissects oncologic drivers and radiotherapy responses in glioblastomaS John Liu, Christopher Zou, Joanna Pak, et al.
Pageof 51